MAP4K4-IN-3 (Compound 17) is a serine/threonine kinase inhibitor with potential as an antidiabetic agent. It is a research tool for studying MAP4K4s role in insulin resistance and metabolic disease, applicable in both cellular and animal models.
Molekulargewicht:
297.74
Reinheit:
99.50% (May vary between batches)
CAS Nummer:
[1811510-58-3]
Formel:
C15H12ClN5
Target-Kategorie:
MAPK
Anwendungsbeschreibung:
Solubility: DMSO:8 mg/mL (26.87 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten